THIOTEPA

THIOTEPA was reported 9762 times

THIOTEPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NPM1 GENE MUTATION 11 0.7857
1 LUNG DISEASE INFECTIVE EXACERBATION 16 0.5926
2 PRE-ENGRAFTMENT IMMUNE REACTION 47 0.5875
3 BACILLE CALMETTE-GUERIN SCAR REACTIVATION 6 0.5000
4 CYTOMEGALOVIRUS URINARY TRACT INFECTION 15 0.4839
5 HYPOGONADISM FEMALE 8 0.4706
6 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 21 0.3559
7 PULMONARY ARTERIOPATHY 16 0.3200
8 ACUTE GRAFT VERSUS HOST DISEASE ORAL 9 0.2903
9 ADENOVIRUS REACTIVATION 40 0.2778
10 HEPATIC IRON OVERLOAD 6 0.2609
11 URETHRAL POLYP 10 0.2500
12 JUVENILE MELANOMA BENIGN 14 0.2121
13 VIRAL HAEMORRHAGIC CYSTITIS 149 0.2093
14 DISSEMINATED TOXOPLASMOSIS 24 0.2000
15 RETINOPATHY HAEMORRHAGIC 13 0.1970
16 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 278 0.1967
17 RADIATION MYELOPATHY 9 0.1957
18 ENGRAFTMENT SYNDROME 113 0.1912
19 ALVEOLAR SOFT PART SARCOMA 7 0.1892
20 HYPERFIBRINOGENAEMIA 12 0.1791
21 CEREBRAL CAVERNOUS MALFORMATION 8 0.1778
22 VIRURIA 19 0.1759
23 HUMAN HERPESVIRUS 6 VIRAEMIA 7 0.1750
24 GASTROENTERITIS ASTROVIRAL 14 0.1750
25 HEART FAILURE WITH MIDRANGE EJECTION FRACTION 10 0.1695
26 ANISOMETROPIA 11 0.1692
27 CHIMERISM 15 0.1685
28 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 464 0.1677
29 HUMAN HERPESVIRUS 6 INFECTION 305 0.1612
30 GASTROENTERITIS ADENOVIRUS 25 0.1592
31 IDIOPATHIC PNEUMONIA SYNDROME 46 0.1544
32 AUTOIMMUNE PANCYTOPENIA 14 0.1538
33 HERPES SIMPLEX PNEUMONIA 19 0.1496
34 SERRATIA SEPSIS 16 0.1481
35 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 28 0.1474
36 RADIATION INTERACTION 11 0.1325
37 MENINGITIS ENTEROCOCCAL 10 0.1266
38 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 9 0.1250
39 GRAFT VERSUS HOST DISEASE IN SKIN 269 0.1220
40 ADENOVIRUS INFECTION 345 0.1188
41 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 107 0.1156
42 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 246 0.1155
43 MEDULLOBLASTOMA RECURRENT 13 0.1150
44 SUBACUTE SCLEROSING PANENCEPHALITIS 5 0.1136
45 URINARY TRACT INFECTION VIRAL 12 0.1132
46 PERIORBITAL INFECTION 9 0.1111
47 TOXIC ERYTHEMA OF CHEMOTHERAPY 27 0.1042
48 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 18 0.1040
49 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 74 0.1029
50 CYTOMEGALOVIRUS INFECTION REACTIVATION 454 0.1027
51 ACUTE GRAFT VERSUS HOST DISEASE 465 0.1015
52 UNDIFFERENTIATED SARCOMA 5 0.0980
53 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 14 0.0979
54 ENTEROCOLITIS VIRAL 29 0.0954
55 GRAFT VERSUS HOST DISEASE IN LIVER 68 0.0950
56 BRONCHIOLITIS OBLITERANS SYNDROME 16 0.0914
57 HUMAN HERPESVIRUS 7 INFECTION 7 0.0886
58 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 32 0.0879
59 VACCINATION SITE INFLAMMATION 5 0.0877
60 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 5 0.0847
61 VENOOCCLUSIVE LIVER DISEASE 416 0.0842
62 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 29 0.0826
63 BONE SARCOMA 16 0.0825
64 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 19 0.0776
65 PSEUDOBULBAR PALSY 6 0.0759
66 CHRONIC GRAFT VERSUS HOST DISEASE 269 0.0744
67 PULMONARY VASCULAR DISORDER 35 0.0743
68 MEDULLOBLASTOMA 11 0.0738
69 VENOOCCLUSIVE DISEASE 184 0.0734
70 ENCEPHALITIS VIRAL 89 0.0731
71 OSTEOSARCOMA 28 0.0727
72 HUMAN HERPESVIRUS 6 ENCEPHALITIS 20 0.0704
73 PULMONARY BLASTOMYCOSIS 8 0.0696
74 HEPATOSPLENIC CANDIDIASIS 10 0.0680
75 PARAINFLUENZA VIRUS INFECTION 7 0.0680
76 CYSTITIS VIRAL 26 0.0679
77 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 6 0.0674
78 VIRAEMIA 92 0.0664
79 BK VIRUS INFECTION 213 0.0631
80 COLITIS EROSIVE 10 0.0629
81 CONGENITAL APLASIA 19 0.0611
82 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 77 0.0585
83 STENOTROPHOMONAS SEPSIS 7 0.0579
84 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 7 0.0574
85 HUMAN POLYOMAVIRUS INFECTION 30 0.0565
86 SEVERE ACUTE RESPIRATORY SYNDROME 12 0.0545
87 GRAFT COMPLICATION 31 0.0528
88 ADENOVIRUS TEST POSITIVE 5 0.0526
89 HERPES SIMPLEX REACTIVATION 20 0.0525
90 ENGRAFT FAILURE 15 0.0523
91 MUCOSAL TOXICITY 14 0.0517
92 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 10 0.0493
93 FOCAL NODULAR HYPERPLASIA 25 0.0481
94 GRAFT VERSUS HOST DISEASE IN EYE 11 0.0476
95 VIRAL DIARRHOEA 16 0.0465
96 REFRACTORINESS TO PLATELET TRANSFUSION 5 0.0459
97 B-CELL LYMPHOMA REFRACTORY 4 0.0449
98 PARVOVIRUS B19 INFECTION 40 0.0447
99 HEPATIC VEIN OCCLUSION 7 0.0443
100 GRAFT VERSUS HOST DISEASE 317 0.0440
101 CHROMOSOMAL DELETION 7 0.0440
102 EPSTEIN-BARR VIRAEMIA 48 0.0433
103 PULMONARY VENO-OCCLUSIVE DISEASE 30 0.0429
104 TRANSPLANT FAILURE 104 0.0424
105 RETINITIS VIRAL 5 0.0413
106 ROSEOLOVIRUS TEST POSITIVE 5 0.0410
107 HERPES SIMPLEX VIRAEMIA 5 0.0400
108 CNS VENTRICULITIS 13 0.0399
109 ENCEPHALITIS CYTOMEGALOVIRUS 17 0.0388
110 COMPLICATIONS OF BONE MARROW TRANSPLANT 14 0.0388
111 DEVICE RELATED BACTERAEMIA 12 0.0387
112 AUTOIMMUNE NEUTROPENIA 11 0.0381
113 EPIDURAL LIPOMATOSIS 13 0.0378
114 GROWTH HORMONE DEFICIENCY 15 0.0378
115 CYTOMEGALOVIRUS VIRAEMIA 167 0.0375
116 CITROBACTER INFECTION 16 0.0373
117 BLOOD STEM CELL TRANSPLANT FAILURE 8 0.0372
118 PARVOVIRUS INFECTION 15 0.0371
119 PNEUMONIA CYTOMEGALOVIRAL 72 0.0370
120 CYSTITIS HAEMORRHAGIC 148 0.0367
121 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 17 0.0364
122 BONE MARROW TRANSPLANT REJECTION 8 0.0364
123 CENTRAL NERVOUS SYSTEM NECROSIS 10 0.0364
124 POLYOMAVIRUS VIRAEMIA 38 0.0358
125 ENTEROBACTER SEPSIS 13 0.0351
126 MYCOBACTERIUM HAEMOPHILUM INFECTION 10 0.0350
127 ACUTE MYELOID LEUKAEMIA REFRACTORY 6 0.0349
128 PARAINFLUENZAE VIRUS INFECTION 52 0.0341
129 KLEBSIELLA URINARY TRACT INFECTION 9 0.0340
130 METAPLASIA 16 0.0339
131 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 87 0.0337
132 LOWER RESPIRATORY TRACT INFECTION VIRAL 17 0.0336
133 MENINGOENCEPHALITIS HERPETIC 15 0.0335
134 EPSTEIN-BARR VIRUS INFECTION 209 0.0334
135 PSEUDOMONAL SEPSIS 58 0.0331
136 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 30 0.0324
137 CYTOMEGALOVIRUS INFECTION 531 0.0319
138 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE 7 0.0318
139 MUCOSAL INFLAMMATION 830 0.0317
140 HAEMATOTOXICITY 301 0.0316
141 SIGHT DISABILITY 6 0.0316
142 GRAFT VERSUS HOST DISEASE IN LUNG 15 0.0314
143 CYTOMEGALOVIRUS CHORIORETINITIS 61 0.0312
144 PNEUMONIA ADENOVIRAL 6 0.0303
145 PARENTERAL NUTRITION 7 0.0303
146 CEREBRAL TOXOPLASMOSIS 28 0.0300
147 GASTROINTESTINAL MUCORMYCOSIS 5 0.0299
148 TRANSPLANT DYSFUNCTION 53 0.0297
149 SERRATIA INFECTION 22 0.0295
150 THROMBOPHLEBITIS SEPTIC 6 0.0293
151 GASTROENTERITIS ROTAVIRUS 9 0.0292
152 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 5 0.0287
153 INFECTION REACTIVATION 32 0.0279
154 RESPIRATORY TRACT INFLAMMATION 13 0.0279
155 CENTRAL NERVOUS SYSTEM LYMPHOMA 38 0.0276
156 ANGIODYSPLASIA 10 0.0275
157 THROMBOTIC MICROANGIOPATHY 267 0.0274
158 SHORT STATURE 7 0.0267
159 INTESTINAL PROLAPSE 11 0.0263
160 TRANSPLANTATION COMPLICATION 11 0.0262
161 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 6 0.0261
162 MELANODERMA 5 0.0260
163 FUSARIUM INFECTION 18 0.0257
164 ADENOVIRAL HEPATITIS 6 0.0255
165 LEUKAEMIA RECURRENT 43 0.0254
166 JEJUNAL ULCER 5 0.0248
167 BACTERIAL SEPSIS 80 0.0245
168 RETINAL SCAR 11 0.0239
169 ENTEROCOCCAL BACTERAEMIA 25 0.0236
170 REFRACTORY CANCER 5 0.0234
171 B-CELL APLASIA 6 0.0233
172 HYPERFERRITINAEMIA 10 0.0232
173 LOWER RESPIRATORY TRACT INFECTION FUNGAL 9 0.0231
174 KLEBSIELLA SEPSIS 26 0.0231
175 RHINOCEREBRAL MUCORMYCOSIS 8 0.0231
176 JC VIRUS INFECTION 36 0.0225
177 CYTOMEGALOVIRUS ENTERITIS 8 0.0225
178 ENCEPHALITIS HERPES 11 0.0223
179 AUTOIMMUNE HAEMOLYTIC ANAEMIA 76 0.0222
180 STENOTROPHOMONAS INFECTION 30 0.0221
181 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 8 0.0220
182 MUCOCUTANEOUS ULCERATION 5 0.0220
183 VOCAL CORD THICKENING 7 0.0220
184 T-LYMPHOCYTE COUNT DECREASED 15 0.0220
185 VASCULAR PSEUDOANEURYSM RUPTURED 5 0.0216
186 HERPES SIMPLEX ENCEPHALITIS 10 0.0216
187 SYSTEMIC CANDIDA 54 0.0215
188 TOXOPLASMOSIS 23 0.0213
189 POLYSEROSITIS 9 0.0211
190 EUSTACHIAN TUBE DYSFUNCTION 12 0.0208
191 RELAPSING FEVER 6 0.0208
192 BLINDNESS CORTICAL 10 0.0204
193 ACUTE DISSEMINATED ENCEPHALOMYELITIS 7 0.0202
194 EYE INFECTION TOXOPLASMAL 8 0.0202
195 STEM CELL TRANSPLANT 49 0.0196
196 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 98 0.0192
197 MUCOSAL DISORDER 19 0.0191
198 LIP ULCERATION 22 0.0188
199 NODULAR REGENERATIVE HYPERPLASIA 12 0.0187
200 APLASIA 36 0.0184
201 MORAXELLA INFECTION 5 0.0182
202 FEEDING INTOLERANCE 8 0.0177
203 PNEUMOCYSTIS JIROVECII INFECTION 21 0.0176
204 ACUTE POLYNEUROPATHY 5 0.0175
205 STREPTOCOCCAL BACTERAEMIA 19 0.0175
206 VARICELLA ZOSTER VIRUS INFECTION 36 0.0173
207 PAROTITIS 20 0.0172
208 GASTROENTERITIS CLOSTRIDIAL 6 0.0171
209 FUNGAL SEPSIS 14 0.0168
210 GASTROINTESTINAL TOXICITY 81 0.0168
211 AGNOSIA 4 0.0168
212 CARDIAC FAILURE HIGH OUTPUT 4 0.0166
213 ENTEROBACTER BACTERAEMIA 5 0.0165
214 NEOPLASM RECURRENCE 56 0.0165
215 APLASTIC ANAEMIA 86 0.0164
216 CEREBRAL ASPERGILLOSIS 10 0.0163
217 APOPTOSIS 5 0.0162
218 KLEBSIELLA BACTERAEMIA 15 0.0158
219 TYPHOID FEVER 5 0.0157
220 CANDIDA SEPSIS 14 0.0156
221 LOSS OF PROPRIOCEPTION 5 0.0155
222 SYSTEMIC MYCOSIS 18 0.0154
223 METAPNEUMOVIRUS INFECTION 12 0.0153
224 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 27 0.0153
225 CRYPTOSPORIDIOSIS INFECTION 8 0.0152
226 GASTROENTERITIS NOROVIRUS 20 0.0150
227 OVARIAN FAILURE 8 0.0150
228 CYTOMEGALOVIRUS COLITIS 34 0.0148
229 GRAFT INFECTION 5 0.0147
230 TERMINAL ILEITIS 9 0.0147
231 BLOOD BILIRUBIN DECREASED 9 0.0146
232 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 139 0.0145
233 SOFT TISSUE SARCOMA 5 0.0143
234 GROWTH RETARDATION 42 0.0143
235 LEUKOENCEPHALOPATHY 53 0.0142
236 MYELITIS TRANSVERSE 20 0.0142
237 SCEDOSPORIUM INFECTION 10 0.0142
238 CEREBRAL FUNGAL INFECTION 4 0.0141
239 FUNGAEMIA 22 0.0140
240 DIFFUSE ALVEOLAR DAMAGE 16 0.0139
241 TOXIC LEUKOENCEPHALOPATHY 10 0.0138
242 OBLITERATIVE BRONCHIOLITIS 18 0.0137
243 HERPES SIMPLEX 89 0.0137
244 GASTROINTESTINAL FUNGAL INFECTION 7 0.0136
245 PULMONARY MUCORMYCOSIS 7 0.0133
246 RESPIRATORY TRACT INFECTION FUNGAL 7 0.0133
247 HAEMATOLOGICAL INFECTION 32 0.0131
248 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 11 0.0130
249 RETINAL INJURY 10 0.0130
250 B-CELL LYMPHOMA RECURRENT 7 0.0129
251 B PRECURSOR TYPE ACUTE LEUKAEMIA 5 0.0129
252 PSEUDOMONAL BACTERAEMIA 11 0.0129
253 FEBRILE NEUTROPENIA 853 0.0128
254 MYCOPLASMA INFECTION 10 0.0128
255 GASTROENTERITIS ESCHERICHIA COLI 7 0.0128
256 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 131 0.0127
257 SEROSITIS 7 0.0127
258 CAPILLARY LEAK SYNDROME 26 0.0126
259 NEUTROPENIC COLITIS 26 0.0126
260 BODY HEIGHT BELOW NORMAL 8 0.0124
261 MINIMAL RESIDUAL DISEASE 6 0.0124
262 MUCORMYCOSIS 32 0.0123
263 KLEBSIELLA INFECTION 62 0.0122
264 PNEUMOCOCCAL SEPSIS 8 0.0122
265 ELECTROLYTE DEPLETION 6 0.0122
266 ROTAVIRUS INFECTION 7 0.0122
267 RIGHT VENTRICULAR DILATATION 7 0.0121
268 CENTRAL HYPOTHYROIDISM 4 0.0121
269 HYPOPITUITARISM 21 0.0121
270 PREMATURE MENOPAUSE 11 0.0119
271 COMPLICATIONS OF TRANSPLANT SURGERY 6 0.0119
272 PNEUMOCOCCAL INFECTION 7 0.0118
273 BRONCHOPULMONARY ASPERGILLOSIS 91 0.0117
274 HYPOGAMMAGLOBULINAEMIA 77 0.0117
275 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 17 0.0117
276 VANISHING BILE DUCT SYNDROME 13 0.0117
277 MANTLE CELL LYMPHOMA RECURRENT 5 0.0115
278 PHARYNGEAL ULCERATION 15 0.0113
279 PLASMA CELL MYELOMA REFRACTORY 15 0.0112
280 PULMONARY VASCULITIS 6 0.0112
281 STAPHYLOCOCCAL SEPSIS 54 0.0109
282 IMMUNE THROMBOCYTOPENIA 50 0.0109
283 PNEUMONIA FUNGAL 43 0.0109
284 EPIDERMOLYSIS 5 0.0109
285 LOCKED-IN SYNDROME 5 0.0108
286 CAMPYLOBACTER INFECTION 9 0.0108
287 ASPERGILLUS INFECTION 71 0.0108
288 MICROANGIOPATHY 10 0.0106
289 PNEUMONIA STAPHYLOCOCCAL 21 0.0106
290 ENTEROCOCCAL INFECTION 51 0.0105
291 MYELOPATHY 20 0.0105
292 ENTEROVIRUS INFECTION 9 0.0104
293 ACUTE MYELOID LEUKAEMIA RECURRENT 22 0.0102
294 CENTRAL NERVOUS SYSTEM LEUKAEMIA 4 0.0102
295 CRYSTAL NEPHROPATHY 6 0.0101
296 STREPTOCOCCAL SEPSIS 12 0.0101
297 HEPATITIS B REACTIVATION 32 0.0101
298 DRUG CLEARANCE DECREASED 13 0.0099
299 ASPERGILLOSIS 13 0.0099
300 DYSMETRIA 6 0.0099
301 FUNGAL OESOPHAGITIS 7 0.0099
302 PELVIC FLUID COLLECTION 7 0.0099
303 MULTIPLE ORGAN DYSFUNCTION SYNDROME 280 0.0099
304 PHARYNGEAL INFLAMMATION 12 0.0099
305 OESOPHAGEAL ULCER HAEMORRHAGE 5 0.0098
306 PNEUMONIA KLEBSIELLA 18 0.0098
307 RETINAL EXUDATES 9 0.0096
308 CORYNEBACTERIUM INFECTION 5 0.0093
309 SOFT TISSUE INFECTION 17 0.0093
310 MOLLUSCUM CONTAGIOSUM 5 0.0093
311 STAPHYLOCOCCAL BACTERAEMIA 40 0.0092
312 SKIN TOXICITY 52 0.0092
313 BACTERAEMIA 109 0.0092
314 RHINOVIRUS INFECTION 35 0.0090
315 ENTEROBACTER INFECTION 15 0.0089
316 CAECITIS 4 0.0089
317 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 7 0.0089
318 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 66 0.0088
319 SKIN BACTERIAL INFECTION 7 0.0087
320 CLOSTRIDIUM DIFFICILE COLITIS 92 0.0087
321 ENTEROCOCCAL SEPSIS 7 0.0086
322 PNEUMONIA INFLUENZAL 10 0.0084
323 PSEUDOMONAS INFECTION 71 0.0083
324 CAROTID ARTERY THROMBOSIS 7 0.0082
325 RENAL TUBULAR INJURY 10 0.0082
326 NEUROLOGICAL DECOMPENSATION 19 0.0082
327 NOCARDIOSIS 21 0.0082
328 AXONAL NEUROPATHY 7 0.0080
329 WEST NILE VIRAL INFECTION 6 0.0080
330 BACILLUS INFECTION 5 0.0079
331 GASTROINTESTINAL BACTERIAL INFECTION 9 0.0079
332 EPIDIDYMITIS 9 0.0077
333 MYOPERICARDITIS 6 0.0077
334 ACUTE RESPIRATORY DISTRESS SYNDROME 133 0.0075
335 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 7 0.0074
336 OPTIC ATROPHY 12 0.0074
337 STEROID DIABETES 11 0.0073
338 DYSBIOSIS 6 0.0073
339 CYTOMEGALOVIRUS TEST POSITIVE 13 0.0073
340 ASTIGMATISM 11 0.0073
341 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 17 0.0072
342 CSF PROTEIN INCREASED 6 0.0072
343 CRANIAL NERVE DISORDER 5 0.0072
344 IDIOSYNCRATIC DRUG REACTION 7 0.0071
345 PULMONARY HAEMORRHAGE 55 0.0070
346 CYTOPENIA 86 0.0070
347 ADENOCARCINOMA PANCREAS 9 0.0070
348 RESPIRATORY SYNCYTIAL VIRUS INFECTION 61 0.0070
349 MYCOBACTERIUM ABSCESSUS INFECTION 5 0.0070
350 VASOGENIC CEREBRAL OEDEMA 5 0.0069
351 PARAPLEGIA 20 0.0069
352 APALLIC SYNDROME 5 0.0069
353 PULMONARY SEPSIS 10 0.0069
354 BONE MARROW TRANSPLANT 13 0.0068
355 OSMOTIC DEMYELINATION SYNDROME 5 0.0068
356 PULMONARY ALVEOLAR HAEMORRHAGE 38 0.0068
357 ENTEROCOLITIS 39 0.0067
358 NEUTROPENIC SEPSIS 48 0.0067
359 MUCOSAL EROSION 6 0.0066
360 METASTASES TO MENINGES 15 0.0066
361 MUCOUS MEMBRANE DISORDER 9 0.0066
362 PNEUMOCYSTIS JIROVECII PNEUMONIA 66 0.0066
363 NEUROTOXICITY 114 0.0065
364 NEPHROPATHY TOXIC 73 0.0065
365 IRON OVERLOAD 7 0.0065
366 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 53 0.0064
367 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 32 0.0064
368 ESCHERICHIA BACTERAEMIA 15 0.0064
369 SECOND PRIMARY MALIGNANCY 52 0.0062
370 ENCEPHALITIS 43 0.0062
371 CONTINUOUS HAEMODIAFILTRATION 6 0.0061
372 BONE MARROW FAILURE 123 0.0060
373 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 16 0.0060
374 MANTLE CELL LYMPHOMA 9 0.0059
375 ACUTE PROMYELOCYTIC LEUKAEMIA 6 0.0058
376 BLADDER DYSFUNCTION 6 0.0058
377 DEAFNESS NEUROSENSORY 19 0.0058
378 PULMONARY ARTERIAL HYPERTENSION 82 0.0057
379 RECURRENT CANCER 23 0.0056
380 JUGULAR VEIN THROMBOSIS 10 0.0056
381 RESPIRATORY TRACT INFECTION VIRAL 13 0.0056
382 HYPERPLASIA 5 0.0056
383 NOROVIRUS INFECTION 8 0.0055
384 URINARY TRACT INFECTION BACTERIAL 14 0.0055
385 ESCHERICHIA SEPSIS 16 0.0055
386 HYPERBILIRUBINAEMIA 57 0.0055
387 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 12 0.0054
388 ENTEROCOLITIS INFECTIOUS 5 0.0054
389 FEBRILE BONE MARROW APLASIA 23 0.0054
390 DIABETES INSIPIDUS 13 0.0054
391 HEPATORENAL SYNDROME 9 0.0053
392 OVARIAN DISORDER 5 0.0053
393 ACUTE LYMPHOCYTIC LEUKAEMIA 15 0.0053
394 VITH NERVE PARALYSIS 6 0.0053
395 HAEMOLYTIC URAEMIC SYNDROME 12 0.0052
396 HYDROCEPHALUS 28 0.0051
397 HYPERTENSIVE EMERGENCY 6 0.0051
398 MITRAL VALVE DISEASE 9 0.0051
399 EMPYEMA 10 0.0050
400 PNEUMONIA VIRAL 16 0.0050
401 ATYPICAL PNEUMONIA 15 0.0050
402 BLOOD CULTURE POSITIVE 15 0.0050
403 BRAIN NEOPLASM 46 0.0050
404 RECTAL PROLAPSE 6 0.0050
405 HEPATOTOXICITY 110 0.0049
406 CARDIOTOXICITY 44 0.0049
407 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 4 0.0049
408 STAPHYLOCOCCAL SKIN INFECTION 6 0.0049
409 TRANSPLANT REJECTION 39 0.0049
410 BLOOD IMMUNOGLOBULIN G DECREASED 12 0.0048
411 LYMPHOPENIA 68 0.0048
412 ESCHERICHIA INFECTION 39 0.0047
413 GASTROINTESTINAL INFLAMMATION 37 0.0047
414 ENTERITIS 30 0.0047
415 HEPATOSPLENOMEGALY 12 0.0047
416 PLATELET TRANSFUSION 6 0.0047
417 PAPILLARY THYROID CANCER 8 0.0046
418 PNEUMONIA PSEUDOMONAL 7 0.0046
419 SEPTIC SHOCK 197 0.0045
420 CYTOKINE RELEASE SYNDROME 88 0.0044
421 PERICARDIAL EFFUSION 99 0.0043
422 INTENSIVE CARE 6 0.0042
423 ACUTE LUNG INJURY 5 0.0042
424 MYELODYSPLASTIC SYNDROME 61 0.0042
425 LABILE BLOOD PRESSURE 5 0.0042
426 LYMPHOPROLIFERATIVE DISORDER 12 0.0041
427 MULTI-ORGAN DISORDER 8 0.0041
428 BACTERIAL TEST POSITIVE 9 0.0040
429 CEREBRAL ATROPHY 16 0.0040
430 CARDIAC TAMPONADE 19 0.0040
431 SUSPECTED OFF LABEL USE 18 0.0040
432 WHITE MATTER LESION 5 0.0040
433 BLOOD BILIRUBIN ABNORMAL 5 0.0039
434 CALCULUS URINARY 6 0.0039
435 ENDOCRINE DISORDER 5 0.0039
436 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
437 MYELITIS 6 0.0039
438 HAEMATOLOGICAL MALIGNANCY 11 0.0039
439 ORGANISING PNEUMONIA 19 0.0038
440 RETINAL HAEMORRHAGE 27 0.0038
441 VITRITIS 7 0.0038
442 SEPSIS 418 0.0037
443 VASCULAR DEVICE INFECTION 17 0.0037
444 TRISMUS 19 0.0037
445 HEPATIC NEOPLASM 12 0.0037
446 NEUROLOGICAL SYMPTOM 21 0.0037
447 ACINETOBACTER INFECTION 4 0.0037
448 CEREBELLAR SYNDROME 8 0.0036
449 PORTAL HYPERTENSION 11 0.0036
450 THROMBOCYTOPENIA 398 0.0036
451 IMMUNE THROMBOCYTOPENIC PURPURA 10 0.0035
452 MULTI-ORGAN FAILURE 61 0.0035
453 GUILLAIN-BARRE SYNDROME 17 0.0035
454 MENINGITIS BACTERIAL 5 0.0035
455 MYCOBACTERIAL INFECTION 6 0.0035
456 RETINITIS 6 0.0035
457 BACTERIAL INFECTION 64 0.0034
458 POLYMYOSITIS 6 0.0034
459 OESOPHAGEAL ULCER 13 0.0034
460 CANDIDA INFECTION 57 0.0034
461 SUBILEUS 7 0.0034
462 CARDIOPULMONARY FAILURE 13 0.0033
463 THERAPY PARTIAL RESPONDER 52 0.0033
464 PNEUMOMEDIASTINUM 6 0.0033
465 RESPIRATORY FAILURE 242 0.0033
466 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5 0.0033
467 ASCITES 97 0.0033
468 SUBDURAL HAEMORRHAGE 9 0.0033
469 PANCYTOPENIA 183 0.0033
470 STAPHYLOCOCCAL INFECTION 108 0.0033
471 ACUTE PULMONARY OEDEMA 18 0.0032
472 VISUAL FIELD DEFECT 23 0.0032
473 HEPATITIS E 5 0.0032
474 BRAIN ABSCESS 8 0.0032
475 THROMBOPHLEBITIS 11 0.0031
476 ENCEPHALOPATHY 77 0.0031
477 PNEUMONIA LEGIONELLA 5 0.0031
478 RESPIRATORY DISTRESS 86 0.0031
479 NEUTROPENIA 422 0.0031
480 ACUTE LEUKAEMIA 5 0.0031
481 PNEUMONITIS 84 0.0031
482 ATROPHY 6 0.0031
483 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
484 DERMATITIS BULLOUS 22 0.0030
485 HEPATITIS FULMINANT 9 0.0030
486 HISTIOCYTOSIS HAEMATOPHAGIC 9 0.0030
487 INFLAMMATORY MARKER INCREASED 15 0.0030
488 HEPATIC FAILURE 91 0.0030
489 QUADRIPARESIS 5 0.0030
490 INFECTION 435 0.0030
491 LUNG ADENOCARCINOMA 9 0.0030
492 DIFFUSE LARGE B-CELL LYMPHOMA 23 0.0030
493 OESOPHAGITIS 32 0.0029
494 BLOOD AMYLASE INCREASED 5 0.0029
495 ATRIAL THROMBOSIS 6 0.0029
496 LYMPHADENITIS 7 0.0029
497 DRUG TOXICITY 39 0.0029
498 ATRIAL TACHYCARDIA 6 0.0029
499 HEPATOMEGALY 28 0.0028
500 IMMUNOSUPPRESSION 25 0.0028
501 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
502 SHOCK HAEMORRHAGIC 23 0.0028
503 PORTAL VEIN THROMBOSIS 9 0.0028
504 ACUTE MYELOID LEUKAEMIA 43 0.0028
505 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 16 0.0027
506 DIFFUSE ALOPECIA 5 0.0027
507 PERIPHERAL VENOUS DISEASE 11 0.0027
508 PNEUMOCYSTIS JIROVECI PNEUMONIA 6 0.0027
509 CARDIAC DYSFUNCTION 10 0.0027
510 MALABSORPTION 14 0.0027
511 LUNG OPACITY 7 0.0027
512 FUNGAL INFECTION 88 0.0026
513 OSTEOPOROTIC FRACTURE 5 0.0026
514 CLOSTRIDIUM DIFFICILE INFECTION 57 0.0026
515 AUTOIMMUNE HEPATITIS 18 0.0026
516 ACUTE RESPIRATORY FAILURE 48 0.0025
517 CANDIDIASIS 10 0.0025
518 RENAL TUBULAR DISORDER 7 0.0025
519 DEVICE RELATED SEPSIS 5 0.0025
520 SKIN EROSION 8 0.0025
521 PNEUMATOSIS INTESTINALIS 7 0.0025
522 MYELOSUPPRESSION 88 0.0024
523 PRODUCT USE IN UNAPPROVED INDICATION 601 0.0024
524 LUNG ABSCESS 5 0.0024
525 LEUKAEMIA 22 0.0023
526 HYPOPHOSPHATAEMIA 17 0.0023
527 MULTIPLE-DRUG RESISTANCE 7 0.0023
528 HERPES VIRUS INFECTION 13 0.0023
529 AREFLEXIA 6 0.0022
530 ANAL ABSCESS 12 0.0022
531 STUPOR 7 0.0022
532 ATELECTASIS 21 0.0022
533 LUNG CONSOLIDATION 6 0.0021
534 HAEMORRHAGE INTRACRANIAL 32 0.0021
535 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
536 CHOLESTASIS 41 0.0021
537 MYOCARDITIS 24 0.0021
538 SPEECH DISORDER DEVELOPMENTAL 6 0.0021
539 TOXIC SKIN ERUPTION 21 0.0021
540 BRONCHIECTASIS 14 0.0021
541 PNEUMONIA BACTERIAL 19 0.0021
542 DIARRHOEA HAEMORRHAGIC 19 0.0020
543 HYPERVOLAEMIA 10 0.0020
544 TACHYPHRENIA 7 0.0020
545 ILEUS PARALYTIC 9 0.0020
546 LYMPHOMA 31 0.0020
547 EJECTION FRACTION DECREASED 31 0.0020
548 THROMBOTIC THROMBOCYTOPENIC PURPURA 7 0.0020
549 ORGAN FAILURE 8 0.0020
550 STOMATITIS 119 0.0020
551 DEAFNESS 51 0.0019
552 DRUG RESISTANCE 50 0.0019
553 LUNG INFILTRATION 17 0.0019
554 VIRAL INFECTION 64 0.0019
555 ORAL DISORDER 14 0.0019
556 ELECTROLYTE IMBALANCE 22 0.0019
557 DISEASE RECURRENCE 90 0.0019
558 AUTOIMMUNE THYROIDITIS 7 0.0018
559 HAEMODYNAMIC INSTABILITY 14 0.0018
560 GASTRIC PERFORATION 5 0.0018
561 HYPERTHERMIA 14 0.0018
562 BLOOD BILIRUBIN INCREASED 49 0.0018
563 TRANSFUSION 19 0.0018
564 MENINGITIS 12 0.0018
565 ANGIOPATHY 10 0.0018
566 DRUG TOLERANCE DECREASED 5 0.0018
567 DISEASE PROGRESSION 206 0.0017
568 PERICARDITIS 29 0.0017
569 HYPERTRANSAMINASAEMIA 12 0.0017
570 DERMATITIS EXFOLIATIVE GENERALISED 6 0.0017
571 RENAL FUNCTION TEST ABNORMAL 8 0.0017
572 HYPERREFLEXIA 6 0.0017
573 DEMYELINATION 7 0.0017
574 NYSTAGMUS 9 0.0017
575 ATAXIA 20 0.0017
576 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
577 HYPOVOLAEMIC SHOCK 8 0.0017
578 HYPERCAPNIA 5 0.0017
579 CAROTID ARTERY OCCLUSION 6 0.0016
580 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
581 DERMATITIS 34 0.0016
582 LEUKOPENIA 81 0.0016
583 TACHYPNOEA 22 0.0016
584 NEPHROTIC SYNDROME 11 0.0016
585 PARONYCHIA 7 0.0016
586 PULMONARY HYPERTENSION 33 0.0016
587 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
588 PULMONARY TOXICITY 11 0.0016
589 VIRAL LOAD INCREASED 6 0.0015
590 PYREXIA 533 0.0015
591 PERIPHERAL SENSORY NEUROPATHY 9 0.0015
592 ORAL INFECTION 6 0.0015
593 TRANSAMINASES INCREASED 34 0.0015
594 PLEURAL EFFUSION 92 0.0015
595 ANURIA 13 0.0015
596 THERAPEUTIC AGENT TOXICITY 5 0.0015
597 DEVICE RELATED INFECTION 23 0.0015
598 CLOSTRIDIAL INFECTION 5 0.0015
599 TUMOUR LYSIS SYNDROME 13 0.0015
600 B-CELL LYMPHOMA 5 0.0015
601 KIDNEY TRANSPLANT REJECTION 7 0.0015
602 OLIGURIA 9 0.0014
603 PETECHIAE 15 0.0014
604 ACUTE KIDNEY INJURY 219 0.0014
605 BRONCHIOLITIS 5 0.0014
606 STATUS EPILEPTICUS 16 0.0014
607 NERVOUS SYSTEM DISORDER 44 0.0014
608 HYPERNATRAEMIA 7 0.0014
609 GRANULOCYTOPENIA 8 0.0014
610 OFF LABEL USE 1227 0.0014
611 MYOPATHY 12 0.0014
612 PYELONEPHRITIS 12 0.0014
613 TOXIC ENCEPHALOPATHY 7 0.0014
614 FEEDING DISORDER 28 0.0014
615 ILEUS 17 0.0014
616 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 75 0.0014
617 CORONAVIRUS INFECTION 9 0.0014
618 BRAIN OEDEMA 17 0.0013
619 MALNUTRITION 15 0.0013
620 BRAIN HERNIATION 4 0.0013
621 PAPILLOEDEMA 6 0.0013
622 PATHOGEN RESISTANCE 12 0.0013
623 CHEST X-RAY ABNORMAL 4 0.0013
624 HAEMOLYSIS 10 0.0013
625 CARDIOMYOPATHY 19 0.0013
626 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
627 PERITONITIS 26 0.0013
628 FAECAL INCONTINENCE 6 0.0012
629 AUTOIMMUNE DISORDER 12 0.0012
630 ARTHRITIS BACTERIAL 5 0.0012
631 GENERALISED OEDEMA 15 0.0012
632 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
633 CONGESTIVE CARDIOMYOPATHY 5 0.0012
634 PNEUMOTHORAX 19 0.0012
635 COVID-19 PNEUMONIA 14 0.0012
636 APPENDICITIS 11 0.0012
637 CHOLECYSTITIS 14 0.0012
638 ODYNOPHAGIA 7 0.0012
639 PHLEBITIS 6 0.0012
640 FLUID OVERLOAD 17 0.0012
641 METASTASES TO CENTRAL NERVOUS SYSTEM 15 0.0012
642 PLATELET COUNT ABNORMAL 7 0.0012
643 HYPOALBUMINAEMIA 9 0.0012
644 THERAPY NON-RESPONDER 52 0.0012
645 COAGULOPATHY 19 0.0011
646 BLOOD CREATINE INCREASED 5 0.0011
647 OSTEONECROSIS 37 0.0011
648 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
649 HAEMOLYTIC ANAEMIA 10 0.0011
650 GASTROINTESTINAL INFECTION 10 0.0011
651 ASPHYXIA 9 0.0011
652 HYPOTONIA 11 0.0011
653 HEPATITIS 28 0.0011
654 CENTRAL NERVOUS SYSTEM LESION 15 0.0011
655 MELAENA 24 0.0011
656 GASTRIC ULCER HAEMORRHAGE 6 0.0011
657 INTESTINAL PERFORATION 12 0.0011
658 NEOPLASM PROGRESSION 37 0.0011
659 COLITIS 40 0.0011
660 OSTEOPENIA 16 0.0011
661 ACIDOSIS 8 0.0010
662 CHOLECYSTITIS CHRONIC 7 0.0010
663 INTENTIONAL PRODUCT USE ISSUE 91 0.0010
664 METASTASES TO LUNG 12 0.0010
665 LUNG INFECTION 16 0.0010
666 ANAEMIA 196 0.0010
667 MUCOUS STOOLS 5 0.0010
668 TRICUSPID VALVE INCOMPETENCE 8 0.0010
669 HYPERAMMONAEMIA 5 0.0010
670 SENSORY LOSS 8 0.0010
671 DERMATITIS ACNEIFORM 6 0.0010
672 DELIRIUM 34 0.0010
673 RENAL FAILURE 130 0.0010
674 ORAL HERPES 19 0.0010
675 MENTAL STATUS CHANGES 27 0.0010
676 CEREBRAL ISCHAEMIA 5 0.0010
677 RENAL IMPAIRMENT 81 0.0010
678 PERIORBITAL OEDEMA 5 0.0010
679 MAJOR DEPRESSION 7 0.0010
680 HYPOKALAEMIA 44 0.0010
681 CARDIAC FAILURE 76 0.0009
682 WHITE BLOOD CELL COUNT ABNORMAL 6 0.0009
683 AORTIC VALVE INCOMPETENCE 4 0.0009
684 HAEMATURIA 32 0.0009
685 SKIN HYPERPIGMENTATION 8 0.0009
686 URINE OUTPUT DECREASED 8 0.0009
687 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
688 RASH MACULO-PAPULAR 20 0.0009
689 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
690 CEREBRAL HAEMORRHAGE 32 0.0009
691 MITRAL VALVE INCOMPETENCE 10 0.0009
692 ACUTE HEPATIC FAILURE 12 0.0009
693 HYPOXIA 30 0.0009
694 DUODENAL ULCER 6 0.0008
695 SEIZURE 98 0.0008
696 HEMIPLEGIA 7 0.0008
697 METASTASIS 6 0.0008
698 MYOCLONUS 10 0.0008
699 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0008
700 HERPES ZOSTER 48 0.0008
701 HAEMODIALYSIS 7 0.0008
702 ASPIRATION 9 0.0008
703 VITREOUS FLOATERS 8 0.0008
704 CHOLANGITIS 5 0.0008
705 BRAIN INJURY 8 0.0008
706 PNEUMONIA 258 0.0008
707 HYPOCALCAEMIA 15 0.0008
708 GASTROINTESTINAL HAEMORRHAGE 66 0.0008
709 PROCTALGIA 5 0.0008
710 CACHEXIA 4 0.0008
711 HEPATITIS ACUTE 5 0.0008
712 HEMIPARESIS 13 0.0008
713 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
714 CARDIOGENIC SHOCK 11 0.0008
715 SUDDEN DEATH 8 0.0008
716 AGRANULOCYTOSIS 14 0.0008
717 HEPATITIS C 9 0.0007
718 METASTASES TO LYMPH NODES 5 0.0007
719 IMMUNODEFICIENCY 11 0.0007
720 HYPERTENSION 156 0.0007
721 DRUG ERUPTION 13 0.0007
722 CARDIOMEGALY 9 0.0007
723 SMALL INTESTINAL OBSTRUCTION 9 0.0007
724 LIVER DISORDER 32 0.0007
725 LARGE INTESTINE PERFORATION 5 0.0007
726 HYPOMAGNESAEMIA 10 0.0007
727 RIGHT VENTRICULAR FAILURE 5 0.0007
728 MALIGNANT NEOPLASM PROGRESSION 72 0.0007
729 GASTROENTERITIS 10 0.0007
730 EUPHORIC MOOD 7 0.0007
731 HAEMOPTYSIS 19 0.0007
732 ASPARTATE AMINOTRANSFERASE INCREASED 36 0.0007
733 CEREBRAL DISORDER 5 0.0007
734 HAEMATEMESIS 17 0.0007
735 CHOKING 13 0.0007
736 MOUTH ULCERATION 14 0.0007
737 COGNITIVE DISORDER 31 0.0007
738 ADRENAL INSUFFICIENCY 8 0.0007
739 RESPIRATORY DEPRESSION 8 0.0007
740 LIPASE INCREASED 5 0.0007
741 HYPERCALCAEMIA 8 0.0006
742 CHRONIC KIDNEY DISEASE 49 0.0006
743 BIPOLAR DISORDER 7 0.0006
744 HEPATOCELLULAR INJURY 9 0.0006
745 TOXICITY TO VARIOUS AGENTS 107 0.0006
746 CARDIAC ARREST 52 0.0006
747 STEVENS-JOHNSON SYNDROME 14 0.0006
748 EPISTAXIS 47 0.0006
749 HYPOTHYROIDISM 20 0.0006
750 EPILEPSY 19 0.0006
751 COVID-19 109 0.0006
752 HYPOKINESIA 9 0.0006
753 RESPIRATORY ARREST 17 0.0006
754 DIPLOPIA 16 0.0006
755 DECUBITUS ULCER 5 0.0006
756 OEDEMA 33 0.0006
757 PULMONARY MASS 9 0.0006
758 CARDIAC FAILURE ACUTE 4 0.0006
759 SPLENOMEGALY 7 0.0006
760 CYSTITIS 19 0.0006
761 PLATELET COUNT DECREASED 63 0.0006
762 NEUTROPHIL COUNT DECREASED 24 0.0006
763 FACIAL PARALYSIS 5 0.0006
764 PROTEINURIA 11 0.0006
765 ALANINE AMINOTRANSFERASE INCREASED 35 0.0006
766 SPINAL OSTEOARTHRITIS 5 0.0006
767 BLINDNESS 23 0.0006
768 PHARYNGITIS 7 0.0006
769 PRODUCT USE ISSUE 106 0.0006
770 MYOSITIS 5 0.0006
771 ANAL INCONTINENCE 5 0.0006
772 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
773 LIP DRY 5 0.0005
774 SKIN HAEMORRHAGE 8 0.0005
775 INTERSTITIAL LUNG DISEASE 26 0.0005
776 CIRCULATORY COLLAPSE 9 0.0005
777 HEPATIC ENZYME INCREASED 36 0.0005
778 COMA 25 0.0005
779 PULMONARY FIBROSIS 10 0.0005
780 JAUNDICE 14 0.0005
781 DYSTONIA 10 0.0005
782 IMPAIRED GASTRIC EMPTYING 7 0.0005
783 PLASMA CELL MYELOMA 20 0.0005
784 RECTAL HAEMORRHAGE 22 0.0005
785 URINARY INCONTINENCE 15 0.0005
786 PRODUCT PRESCRIBING ISSUE 11 0.0005
787 BLOOD ALBUMIN DECREASED 4 0.0005
788 RASH ERYTHEMATOUS 24 0.0005
789 POLYNEUROPATHY 6 0.0005
790 SALIVARY HYPERSECRETION 5 0.0005
791 THERAPEUTIC RESPONSE DECREASED 30 0.0005
792 NO THERAPEUTIC RESPONSE 6 0.0005
793 EYELID PTOSIS 5 0.0005
794 ORAL PAIN 11 0.0005
795 TOOTH ABSCESS 5 0.0005
796 HYPOACUSIS 21 0.0005
797 DRUG-INDUCED LIVER INJURY 15 0.0005
798 SKIN LESION 13 0.0005
799 CONVULSION 27 0.0005
800 TREATMENT FAILURE 39 0.0005
801 POST PROCEDURAL COMPLICATION 9 0.0005
802 HYPOTENSION 94 0.0005
803 DIARRHOEA 301 0.0005
804 APHASIA 14 0.0005
805 HAEMATOMA 12 0.0005
806 OXYGEN SATURATION DECREASED 26 0.0005
807 DRUG ADMINISTRATION ERROR 14 0.0005
808 IMMUNE SYSTEM DISORDER 6 0.0005
809 LYMPHOCYTE COUNT DECREASED 8 0.0005
810 LUNG DISORDER 22 0.0004
811 ISCHAEMIC STROKE 8 0.0004
812 PULMONARY OEDEMA 20 0.0004
813 SKIN INFECTION 5 0.0004
814 LEUKOCYTOSIS 8 0.0004
815 ABDOMINAL PAIN 101 0.0004
816 MANIA 7 0.0004
817 DRUG INEFFECTIVE 558 0.0004
818 DIALYSIS 6 0.0004
819 BLISTER 23 0.0004
820 CARDIO-RESPIRATORY ARREST 17 0.0004
821 DISORIENTATION 16 0.0004
822 RESPIRATORY DISORDER 12 0.0004
823 PANCREATITIS ACUTE 9 0.0004
824 HYPERKALAEMIA 14 0.0004
825 TACHYCARDIA 35 0.0004
826 OSTEOMYELITIS 7 0.0004
827 C-REACTIVE PROTEIN INCREASED 14 0.0004
828 HYPERGLYCAEMIA 14 0.0004
829 GASTRITIS 10 0.0004
830 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 27 0.0004
831 EATING DISORDER 8 0.0004
832 BREAST CANCER METASTATIC 4 0.0004
833 ATRIAL FIBRILLATION 36 0.0004
834 URINARY TRACT INFECTION 63 0.0004
835 VOMITING 173 0.0004
836 URINARY RETENTION 12 0.0004
837 NEUROPATHY PERIPHERAL 34 0.0004
838 SINUS TACHYCARDIA 5 0.0004
839 SUBDURAL HAEMATOMA 5 0.0003
840 RESPIRATORY TRACT INFECTION 9 0.0003
841 NEOPLASM MALIGNANT 23 0.0003
842 HYPONATRAEMIA 19 0.0003
843 VISUAL ACUITY REDUCED 11 0.0003
844 INFLAMMATION 17 0.0003
845 HEPATIC FUNCTION ABNORMAL 12 0.0003
846 CELLULITIS 16 0.0003
847 MUSCULAR WEAKNESS 36 0.0003
848 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
849 DRUG INTERACTION 49 0.0003
850 LOWER RESPIRATORY TRACT INFECTION 14 0.0003
851 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 9 0.0003
852 GASTROINTESTINAL DISORDER 27 0.0003
853 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
854 DYSURIA 11 0.0003
855 MENTAL DISORDER 13 0.0003
856 HAEMORRHAGE 31 0.0003
857 HAEMOGLOBIN DECREASED 30 0.0003
858 OSTEOPOROSIS 12 0.0003
859 COLITIS ULCERATIVE 13 0.0003
860 VISUAL IMPAIRMENT 36 0.0003
861 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
862 CATARACT 17 0.0003
863 COLD SWEAT 5 0.0003
864 RENAL FAILURE ACUTE 12 0.0003
865 LYMPHADENOPATHY 10 0.0003
866 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
867 END STAGE RENAL DISEASE 5 0.0003
868 ANAPHYLACTIC SHOCK 7 0.0003
869 RENAL INJURY 8 0.0003
870 HEPATIC STEATOSIS 5 0.0003
871 DEEP VEIN THROMBOSIS 17 0.0003
872 SHOCK 6 0.0003
873 BLOOD CREATININE INCREASED 17 0.0003
874 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
875 DISTURBANCE IN ATTENTION 14 0.0003
876 AGITATION 19 0.0003
877 BASAL CELL CARCINOMA 4 0.0003
878 CONFUSIONAL STATE 41 0.0003
879 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
880 SPEECH DISORDER 13 0.0002
881 DYSKINESIA 10 0.0002
882 DYSPHAGIA 23 0.0002
883 LIVER FUNCTION TEST ABNORMAL 7 0.0002
884 DRY EYE 12 0.0002
885 ABDOMINAL DISTENSION 25 0.0002
886 BLOOD UREA INCREASED 4 0.0002
887 DRUG INTOLERANCE 23 0.0002
888 LIVER FUNCTION TEST INCREASED 5 0.0002
889 UNRESPONSIVE TO STIMULI 6 0.0002
890 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
891 METABOLIC ACIDOSIS 7 0.0002
892 NECK PAIN 12 0.0002
893 DYSARTHRIA 8 0.0002
894 INFUSION RELATED REACTION 14 0.0002
895 PRESYNCOPE 5 0.0002
896 NEURALGIA 5 0.0002
897 PNEUMONIA ASPIRATION 5 0.0002
898 PULMONARY EMBOLISM 19 0.0002
899 HALLUCINATION 15 0.0002
900 INFLUENZA 22 0.0002
901 CHILLS 23 0.0002
902 RASH 85 0.0002
903 LUNG NEOPLASM MALIGNANT 8 0.0002
904 DEATH 166 0.0002
905 NAUSEA 152 0.0002
906 OEDEMA PERIPHERAL 23 0.0002
907 BRADYCARDIA 10 0.0002
908 TREMOR 31 0.0002
909 CARDIAC FAILURE CONGESTIVE 15 0.0002
910 COUGH 52 0.0002
911 SKIN DISORDER 6 0.0002
912 SOMNOLENCE 36 0.0002
913 THROMBOSIS 14 0.0002
914 WEIGHT INCREASED 37 0.0002
915 CEREBRAL INFARCTION 4 0.0002
916 HAEMATOCHEZIA 9 0.0002
917 CARDIOVASCULAR DISORDER 4 0.0002
918 DEHYDRATION 21 0.0002
919 SKIN EXFOLIATION 13 0.0002
920 DECREASED APPETITE 35 0.0002
921 BRONCHITIS 11 0.0001
922 ALOPECIA 29 0.0001
923 CONDITION AGGRAVATED 44 0.0001
924 MEDICATION ERROR 8 0.0001
925 RASH MACULAR 5 0.0001
926 PARAESTHESIA 22 0.0001
927 ANGINA PECTORIS 4 0.0001
928 SINUSITIS 14 0.0001
929 WHEEZING 8 0.0001
930 IRRITABILITY 8 0.0001
931 INTESTINAL OBSTRUCTION 5 0.0001
932 PANCREATITIS 7 0.0001
933 ERYTHEMA 27 0.0001
934 VERTIGO 8 0.0001
935 OROPHARYNGEAL PAIN 12 0.0001
936 RASH PRURITIC 7 0.0001
937 RENAL DISORDER 6 0.0001
938 ABNORMAL BEHAVIOUR 5 0.0001
939 HYPOGLYCAEMIA 6 0.0001
940 LETHARGY 7 0.0001
941 FLUID RETENTION 6 0.0001
942 ILL-DEFINED DISORDER 7 0.0001
943 HEADACHE 72 0.0001
944 ANGIOEDEMA 5 0.0001
945 SWELLING FACE 7 0.0001
946 BLOOD PRESSURE DECREASED 7 0.0001
947 DYSPHONIA 6 0.0001
948 PAIN 63 0.0001
949 HYPERSENSITIVITY 19 0.0001
950 HYPERHIDROSIS 13 0.0001
951 DISCOMFORT 6 0.0001
952 ILLNESS 10 0.0001
953 VISION BLURRED 13 0.0001
954 DYSPNOEA 53 0.0001
955 ASTHENIA 35 0.0001
956 INTENTIONAL PRODUCT MISUSE 8 0.0001
957 ANAPHYLACTIC REACTION 5 0.0001
958 ADVERSE EVENT 8 0.0001
959 ARRHYTHMIA 4 0.0001
960 DYSGEUSIA 6 0.0001
961 HYPOAESTHESIA 12 0.0001
962 WEIGHT DECREASED 22 0.0001
963 MUSCLE SPASMS 14 0.0001
964 CHEST PAIN 13 0.0001
965 MOBILITY DECREASED 5 0.0001
966 UNDERDOSE 5 0.0001
967 ANXIETY 19 0.0001
968 DRY MOUTH 5 0.0001
969 NO ADVERSE EVENT 11 0.0001
970 ABDOMINAL DISCOMFORT 10 0.0001
971 FATIGUE 45 0.0001
972 MUSCULOSKELETAL STIFFNESS 5 0.0001
973 BACK PAIN 13 0.0001
974 CARDIAC DISORDER 5 0.0001
975 SWELLING 5 0.0001
976 MALAISE 23 0.0001
977 BLOOD PRESSURE INCREASED 8 0.0001
978 PAIN IN EXTREMITY 15 0.0001
979 SYNCOPE 5 0.0000
980 DEPRESSION 11 0.0000
981 MYALGIA 8 0.0000
982 BALANCE DISORDER 4 0.0000
983 GAIT DISTURBANCE 8 0.0000
984 CEREBROVASCULAR ACCIDENT 7 0.0000
985 ABDOMINAL PAIN UPPER 8 0.0000
986 NASOPHARYNGITIS 7 0.0000
987 DIZZINESS 18 0.0000
988 CONSTIPATION 7 0.0000
989 URTICARIA 5 0.0000
990 ARTHRALGIA 12 0.0000
991 OVERDOSE 5 0.0000
992 PRURITUS 6 0.0000